8 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 8 of 8 clinical reviews.
A clinical evidence summary of bremelanotide (PT-141) for female sexual dysfunction, including trial data, FDA-approved indications, off-label considerations, dosing, and safety profile.
A guide to bremelanotide (PT-141) for female sexual dysfunction, covering FDA-approved vs. Off-label use, trial data, dosing, side effects, and who is and isn't a candidate.
How to monitor patients using PT-141 (bremelanotide) for female sexual dysfunction, including blood pressure checks, nausea management, skin assessments, and cardiovascular screening before and during treatment.
Clinical guide to bremelanotide (PT-141) for female sexual dysfunction, including FDA-approved and off-label dosing protocols, trial data from RECONNECT, side effects, and prescribing considerations.
A clinical evidence summary of bremelanotide (PT-141) for male sexual dysfunction, including trial data, dosing, safety, and off-label status.
A comprehensive clinical review of off-label bremelanotide (PT-141) use in men with erectile dysfunction and hypoactive sexual desire disorder, including evidence grading, dosing protocols, and safety monitoring.
A breakdown of off-label bremelanotide use in men with erectile dysfunction and low libido, covering mechanism, trial data, dosing, side effects, and when it may fit a treatment plan.
Bremelanotide (PT-141) is FDA-approved for female HSDD but used off-label for male sexual dysfunction. Review the evidence, dosing protocols, safety data, and how it compares to PDE5 inhibitors.